Skip to content

Evaluation of the efficacy of nimbapatradi arka ashchyotana(topical instillation) and rajanyadi churna orally in the management of vataja abhisyanda- simple allergic conjunctivitis

EVALUATION OF THE EFFICACY OF NIMBAPATRADI ARKA ASHCHYOTANA AND RAJANYADI CHURNA IN VATAJA ABHISYANDA- SIMPLE ALLERGIC CONJUNCTIVITIS-AN OPEN LABEL DOUBLE ARM RANDOMIZED CONTROLLED CLINICAL TRIAL

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/06/043005
Enrollment
40
Registered
2022-06-03
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H108- Other conjunctivitis

Interventions

None listed

Sponsors

All india institute of ayurveda
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients having signs and symptoms of vataja abhisyanda simple allergic conjunctivitis- irrespective of sex, religion, occupation. patients willing to participate in study

Exclusion criteria

Exclusion criteria: patient having viral and bacterial conjunctivitis patient having complicated eye diseases and trachoma, chalazion, stye, pterygium, darcocystitis, trichiasis patient suffering from corneal opacity, ulcer patient suffering from HTN,DM, TB pregnant lady and lactating mothers

Design outcomes

Primary

MeasureTime frame
change in signs and symptoms of vataja abhisyanda like accha ashruta (watering of eyes)Timepoint: 2 month

Secondary

MeasureTime frame
improvement in remaining symptoms like shirobhitapa, nistoda, stambana, ragata, kandu, nimeshonmesa krchraTimepoint: 2 month

Countries

India

Contacts

Public ContactDR Narayan Bavalatti

ALL INDIA INSTITUTE OF AYURVEDA

hod-shalakya@aiia.gov.in9560788850

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026